threo Ifenprodil hemitartrateCat No. 2892 |
Price and Availability |
|
Chemical Name: (1S*,2S*)-threo-2-(4-Benzylpiperidino)-1-(4-hydroxyphen yl)-1-propanol hemitartrate |
|
Biological Activity
Potent σ receptor agonist (Ki values are 59.1 and 2 nM for σ1 and σ2 receptors respectively) and NR2B subunit-selective NMDA receptor antagonist (IC50 values are 0.22 and 324.8 μM at NR2B and NR2A respectively). Displays ~8-fold reduced affinity at α-adrenoceptors compared to Ifenprodil (Cat.No. 0545). Inhibits the hERG potassium channel (IC50 = 88 nM) and exhibits antiarrhythmic activity in vivo.Technical Data
M.Wt:The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
References
Hashimoto and London (1995) Interactions of erythro-ifenprodil, threo-ifenprodil and erythro-iodoifenprodil, and eliprodil with subtypes of σ receptors. Eur.J.Pharmacol. 273 307. Avenet et al (1996) Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur.J.Pharmacol. 296 209. Monassier et al (2007) σ2-receptor ligand-mediated inhibition of inwardly rectifying K+ channels in the heart. J.Pharmacol.Exp.Ther. 322 341.If you know of a useful citation for this product please let us know.
View Related Products by Target
Keywords: threo Ifenprodil hemitartrate, NR2B, selective, NMDA, antagonists, receptors, s, σ, sigma, agonist, ionotropic, glutamate, iGluR
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
Sodium salt of kynurenic acid (Cat. No. 0223)
DL-AP5 Sodium saltSodium salt of DL-AP5 (Cat. No. 0105)
Pep2m, myristoylatedMyristoylated form of pep2m. Peptide inhibitor of GluR2 subunit binding to NSF
TheanineGlutamate receptor ligand
Careers at Tocris
Tocris Bioscience currently has opportunities for a Chemistry Technician.
If you would like to be considered for any positions not currently advertised, we welcome your speculative application.






